Liver Transplant Rejection Risk Mitigation
📧 Sign up to get email alerts when something new happens for Liver Transplant Rejection Risk Mitigation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-02-09Clinical Trial Update: Donor Alloantigen Reactive Tregs (darTregs) for Calcineurin Inhibitor (CNI) Reduction [Phase 1, Phase 2]
A Phase 1/Phase 2 trial evaluating donor alloantigen reactive Tregs (darTregs) for reducing calcineurin inhibitor use in liver transplant re…